mutual funds nippon india pharma fund directgrowth

holdings

Nippon India Pharma Fund Direct-Growth

Equity: Sectoral-Pharma - Growth (Open ended)

Nippon India Pharma Fund Direct-GrowthNAV: 631.76 as on 09 Jul, 2026

Risk levelCategoryBenchmark

Factsheet

SEBI Riskometer: Very HighCategory: Equity: Sectoral-PharmaBenchmark: BSE Healthcare Total Return Index

NAV: ₹631.76+0.34%

10 Jul 2026

Holdings Analysis

Equity, debt and cash allocation snapshot with market cap distribution for Nippon India Pharma Fund Direct-Growth.

Asset Allocation

As on 30 Jun 2026

Equity

97.64%

Others

2.35%

Debt

0.01%

Market Cap Distribution

Large Cap (30.4%)

Mid Cap (41.6%)

Small Cap (28.0%)

Historical Asset Allocation

Asset	30 Jun 2026	31 May 2026	30 Apr 2026	31 Mar 2026	28 Feb 2026	31 Jan 2026
Equity	97.64%	97.98%	98.70%	99.45%	99.68%	98.96%
Debt	0.01%	0.00%	0.01%	0.01%	0.00%	0.00%
Others (incl. cash)	2.35%	2.02%	1.29%	0.54%	0.32%	1.04%
Commodities	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Real Estate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Portfolio Snapshot

No. of Securities

P/E Ratio

38.70

P/B Ratio

5.55

Top Holding %

12.78%

Top 5 Holdings %

38.52%

Top 10 Holdings %

58.09%

AUM

₹9,044 Cr

Expense Ratio

1.00%

Since Inception

17.68%

Max Drawdown

-0.24%

Alpha

-0.73%

Sharpe Ratio

1.00

Top Portfolio Holdings by Weight

Latest portfolio holdings sorted by allocation weight. Includes instrument name, sector, number of shares, market value (₹ Cr) and percentage of net assets. Switch dates or categories using the controls below.

Instrument	Sector	No. of Shares	Value (Rs. Cr)	Weight	Change
Sun Pharmaceutical Industries Ltd.	Healthcare	62,06,349	1,155.93	12.78%	-0.57%↓
Lupin Ltd.	Healthcare	27,83,991	673.45	7.45%	0.14%↑
Dr. Reddys Laboratories Ltd.	Healthcare	44,49,746	603.88	6.68%	-0.04%↓
Cipla Ltd.	Healthcare	37,95,054	556.13	6.15%	-0.01%↓
Divis Laboratories Ltd.	Healthcare	7,50,754	493.92	5.46%	-0.34%↓
Apollo Hospitals Enterprise Ltd.	Healthcare	5,48,795	476.46	5.27%	0.07%↑
Mankind Pharma Ltd.	Healthcare	14,31,195	364.33	4.03%	0.09%↑
Sai Life Sciences Ltd.	Healthcare	25,55,745	315.46	3.49%	0.06%↑
Ajanta Pharma Ltd.	Healthcare	9,13,918	312.81	3.46%	0.25%↑
Max Healthcare Institute Ltd.	Healthcare	26,58,082	300.16	3.32%	0.35%↑
Medplus Health Services Ltd.	Healthcare	35,45,229	287.43	3.18%	-0.50%↓
Vijaya Diagnostic Centre Ltd.	Healthcare	18,71,618	253.16	2.80%	-0.41%↓
Thyrocare Technologies Ltd.	Healthcare	43,66,909	239.87	2.65%	0.09%↑
Ipca Laboratories Ltd.	Healthcare	13,64,742	232.14	2.57%	0.16%↑
Glaxosmithkline Pharmaceuticals Ltd.	Healthcare	9,13,226	223.77	2.47%	0.13%↑
Gland Pharma Ltd.	Healthcare	8,00,549	199.74	2.21%	0.12%↑
Abbott India Ltd.	Healthcare	74,339	189.12	2.09%	-0.22%↓
Alkem Laboratories Ltd.	Healthcare	3,23,678	180.29	1.99%	-0.07%↓
Dr. Lal Pathlabs Ltd.	Healthcare	10,18,224	167.62	1.85%	-0.05%↓
Narayana Hrudayalaya Ltd.	Healthcare	8,23,911	162.45	1.80%	-0.01%↓

1 / 2

Sector-wise Portfolio Allocation

Equity exposure by sector as a percentage of total net assets, tracked across recent portfolio dates. Identifies concentration risk and sector rotation trends in the fund's holdings.

Sector	30 Jun 2026	31 May 2026	30 Apr 2026	31 Mar 2026	28 Feb 2026	31 Jan 2026
Healthcare	97.64%	97.98%	98.70%	99.45%	99.68%	98.96%

Equity Insights

A detailed look at the equity holdings of this scheme — aggregated scores on value, momentum, quality parameters along with diversification and performance analysis.

Style Analysis

Value score

30.7 / 100

Weighted average Value score is 30.7. This indicates that portfolio is relatively reasonably valued using composite of value measures.

Price Momentum score

78.2 / 100

Weighted average Price Momentum score is 78.2. This indicates that portfolio has high momentum using composite of momentum measures.

Quality score

89.6 / 100

Weighted average Quality score is 89.6. This indicates that portfolio has high quality using composite of quality measures.

QVM score

79.3 / 100

Weighted average QVM score is 79.3. This indicates that portfolio has high QVM score and hence could be considered for investment.

Red Flags

Declining revenues

Following companies have seen their sales decline for 2 consecutive quarters (measured on yoy basis): Piramal Pharma Ltd., Sanofi India Ltd.

Frequently Asked Questions

What are the top holdings of Nippon India Pharma Fund Direct-Growth?

The top holdings of Nippon India Pharma Fund Direct-Growth sorted by portfolio weight are listed in the Top Portfolio Holdings section of the Holdings tab.

How many stocks does Nippon India Pharma Fund Direct-Growth hold in its portfolio?

Nippon India Pharma Fund Direct-Growth holds 36 securities in its portfolio. The top 5 holdings account for 38.52% of the portfolio and the top 10 for 58.09%.

What is the sector allocation of Nippon India Pharma Fund Direct-Growth?

The sector allocation of Nippon India Pharma Fund Direct-Growth is in the Sector Allocation section, showing each industry's weight in the portfolio.

What is the equity and debt allocation of Nippon India Pharma Fund Direct-Growth?

As of 30 Jun 2026, Nippon India Pharma Fund Direct-Growth has 97.64% in equity, 0.01% in debt and 2.35% in cash/others. This asset mix determines the fund's overall risk-return profile.

What is the market cap allocation of Nippon India Pharma Fund Direct-Growth?

Nippon India Pharma Fund Direct-Growth's equity portfolio — Large Cap: 30.38%, Mid Cap: 41.59%, Small Cap: 28.03%. Market cap allocation determines the fund's risk profile — large cap offers stability while mid and small cap offer higher growth potential with higher volatility.

Is Nippon India Pharma Fund Direct-Growth a concentrated or diversified fund?

Nippon India Pharma Fund Direct-Growth holds 36 securities, with the top 10 accounting for 58.09% of the portfolio and the top 5 for 38.52%. This is a moderately diversified fund balancing conviction positions with risk spread.

What is the credit quality of Nippon India Pharma Fund Direct-Growth?

The credit quality breakdown of Nippon India Pharma Fund Direct-Growth's debt portfolio is in the Credit Rating section. For equity-oriented funds, this section may not be applicable.

How often does Nippon India Pharma Fund Direct-Growth change its portfolio?

The portfolio currently holds 36 securities with the top 10 accounting for 58.09% as of 30 Jun 2026. Portfolio turnover reflects how actively the fund manager trades. A high turnover increases transaction costs while a low turnover reflects a buy-and-hold approach. Historical asset allocation snapshots across multiple dates are in the Holdings Analysis section.

What is the PE ratio of Nippon India Pharma Fund Direct-Growth's portfolio?

The weighted average PE ratio of Nippon India Pharma Fund Direct-Growth's portfolio is 38.70 and the PB ratio is 5.55. These metrics reflect the overall valuation and interest rate sensitivity of the portfolio.

When is the latest portfolio disclosure for Nippon India Pharma Fund Direct-Growth?

The latest portfolio disclosure for Nippon India Pharma Fund Direct-Growth is as of 30 Jun 2026. Mutual funds and ETFs in India are required to disclose their full portfolio monthly, within 10 business days of month-end. You can switch between historical disclosure dates using the date selector in the Top Portfolio Holdings section.

Loading…

Asset

30 Jun 2026

31 May 2026

30 Apr 2026

31 Mar 2026

28 Feb 2026

31 Jan 2026

Equity

97.64%

97.98%

98.70%

99.45%

99.68%

98.96%

Debt

0.01%

0.00%

0.01%

0.00%

Others (incl. cash)

2.35%

2.02%

1.29%

0.54%

0.32%

1.04%

Commodities

0.00%

Real Estate

0.00%

Instrument

Sector

No. of Shares

Value (Rs. Cr)

Weight

Change

Sun Pharmaceutical Industries Ltd.

Healthcare

62,06,349

1,155.93

12.78%

-0.57%↓

Lupin Ltd.

Healthcare

27,83,991

673.45

7.45%

0.14%↑

Dr. Reddys Laboratories Ltd.

Healthcare

44,49,746

603.88

6.68%

-0.04%↓

Cipla Ltd.

Healthcare

37,95,054

556.13

6.15%

-0.01%↓

Divis Laboratories Ltd.

Healthcare

7,50,754

493.92

5.46%

-0.34%↓

Apollo Hospitals Enterprise Ltd.

Healthcare

5,48,795

476.46

5.27%

0.07%↑

Mankind Pharma Ltd.

Healthcare

14,31,195

364.33

4.03%

0.09%↑

Sai Life Sciences Ltd.

Healthcare

25,55,745

315.46

3.49%

0.06%↑

Ajanta Pharma Ltd.

Healthcare

9,13,918

312.81

3.46%

0.25%↑

Max Healthcare Institute Ltd.

Healthcare

26,58,082

300.16

3.32%

0.35%↑

Medplus Health Services Ltd.

Healthcare

35,45,229

287.43

3.18%

-0.50%↓

Vijaya Diagnostic Centre Ltd.

Healthcare

18,71,618

253.16

2.80%

-0.41%↓

Thyrocare Technologies Ltd.

Healthcare

43,66,909

239.87

2.65%

0.09%↑

Ipca Laboratories Ltd.

Healthcare

13,64,742

232.14

2.57%

0.16%↑

Glaxosmithkline Pharmaceuticals Ltd.

Healthcare

9,13,226

223.77

2.47%

0.13%↑

Gland Pharma Ltd.

Healthcare

8,00,549

199.74

2.21%

0.12%↑

Abbott India Ltd.

Healthcare

74,339

189.12

2.09%

-0.22%↓

Alkem Laboratories Ltd.

Healthcare

3,23,678

180.29

1.99%

-0.07%↓

Dr. Lal Pathlabs Ltd.

Healthcare

10,18,224

167.62

1.85%

-0.05%↓

Narayana Hrudayalaya Ltd.

Healthcare

8,23,911

162.45

1.80%